TriSalus Life Sciences (TLSI) Non Operating Income (2021 - 2023)

TriSalus Life Sciences' Non Operating Income history runs 3 years deep, the most recent figure standing at $477672.0 for Q2 2023.

• On a quarterly basis, Non Operating Income fell 82.33% year-over-year to $477672.0 in Q2 2023; TTM through Jun 2023 was $3.5 million, a 72.54% decrease from a year earlier, with the FY2022 full-year figure at $8.9 million, up 13.42% from the prior year.
• Non Operating Income climbed to $477672.0 in Q2 2023 per TLSI's latest filing, from $422367.0 in the prior quarter.
• Across five years, Non Operating Income topped out at $4.0 million in Q4 2021 and bottomed at -$64042.0 in Q1 2021.
• The 3-year median for Non Operating Income is $1.3 million (2022), against an average of $1.8 million.
• Across the five-year window, Non Operating Income surged 5575.36% in 2022 and slumped 87.95% in 2023, its largest moves.
• Year by year, Non Operating Income stood at $4.0 million in 2021, then sank by 66.22% to $1.4 million in 2022, then plunged by 64.98% to $477672.0 in 2023.
• Per Business Quant, the three latest TLSI Non Operating Income figures stand at $477672.0 (Q2 2023), $422367.0 (Q1 2023), and $1.4 million (Q4 2022).